Study evaluates two multiplex real-time PCR assays for simultaneous detection of MPVX

This study proposes and evaluates two multiplex real-time PCR assays for simultaneous detection and differentiation of monkeypox virus (MPXV) with high specificity and sensitivity.

Immunic to Participate in Investor and Scientific Conferences in February – Biotech Investments

Issuer: Immunic AG / Key word(s): Conference 04.02.2025 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate

February 5, 2025

Home blood pressure monitoring could reduce cardiovascular events, save healthcare costs

Expanding home blood pressure monitoring among US adults with hypertension could substantially reduce the burden of cardiovascular disease and save healthcare costs in the long

July 13, 2023

PF-08046054 by Pfizer for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval

PF-08046054 is under clinical development by Pfizer and currently in Phase I for Head And Neck Squamous Cell Carcinoma (HNSC).

February 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.